A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)
Clinical trial NCT02329327 · COMPLETED
Trial details
- NCT number
- NCT02329327
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-10
- Primary completion
- 2020-09-24
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.